|Bid||85.11 x 1000|
|Ask||85.30 x 1100|
|Day's Range||83.00 - 86.14|
|52 Week Range||62.55 - 101.28|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||18.61|
|Earnings Date||Oct 30, 2020|
|Forward Dividend & Yield||4.72 (5.85%)|
|Ex-Dividend Date||Oct 14, 2020|
|1y Target Est||109.74|
A second term of the Trump administration will continue many of the same policies currently benefiting these stocks.
ABBV earnings call for the period ending September 30, 2020.
Drugmaker AbbVie early Friday posted third-quarter earnings that topped Wall Street's estimates, helped by rising Humira sales. ABBV stock rose solidly after the Q3 earnings report.